Varian readies dose calculator
Mindray marches to marketPACSGEAR moves European office
Varian readies dose calculator
The FDA has cleared a dose calculator for brachytherapy treatment planning. The BrachyVision Acuros product, cleared by the agency for use with Varian Medical Systems’ Eclipse treatment planning system, uses a proprietary method that calculates dose in three to eight minutes. THis compares with the hours it takes using the standard Monte Carlo method. The product, developed by Varian partner Transpire, will be on display July 26 to 30 at the annual meeting of the American Association of Physicists in Medicine in Anaheim, CA.
Mindray marches to market
Mindray Medical International is on track to launch between seven and nine products this year, according to a second-quarter update by the Chinese medical device manufacturer. The company has already released five new products in the first half of 2009. One, the DP-6900, is an upgraded premium portable black-and white ultrasound scanner.
PACSGEAR moves European office
PACS/IT maker PACSGear is relocating its European office to Munich’s high-tech campus, Neue Balan. The company had opened the office elsewhere in Munich less than a year ago. The environmentally friendly green architecture of the Neue Balan campus fits with the firm’s philosophy of eliminating paper from the healthcare process, according to PACSGear.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
